Series 7 Stock Acquisition Rights Subject to ¥2.5 Billion Operating Profit for Fiscal 2026
First written in FY2024-Q1. 2 of 3 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2026-H1.
31 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「As a result, net sales for the six months ended [current interim period] were ¥4,674,389 thousand, up 20.1% year on year; EBITDA was ¥2,043,527 thousand, up 92.0%; operating profit was ¥1,892,205 thousand, up 97.4%; ordinary profit was ¥1,885,445 thousand, up 97.4%; and interim net income attributable to owners of the parent was ¥1,272,321 thousand, up 100.4%.」
In connection with the 7th Series of Share Acquisition Rights, which is subject to operating income exceeding ¥2.5 billion for the fiscal year ending February 2026, operating income for the interim period was ¥1,892.205 million. Achievement of the full-year condition cannot be confirmed from this disclosure. - FY2024-Q2AdvancedAnnual report
「Holders of the share acquisition rights may exercise these rights only if operating income in the consolidated income statement included in the annual securities report for the fiscal year ending February 2026 exceeds ¥2,500 million.」
The 10th Series of Share Acquisition Rights, subject to consolidated operating income exceeding ¥2.5 billion for the fiscal year ending February 2026, was issued to 75 officers and employees of the Company and its subsidiaries, representing 95,800 shares. The scope of holders of share acquisition rights subject to the same operating income condition was expanded. - FY2024-Q1First statedAnnual report
「Holders of the share acquisition rights may exercise these rights only if operating income in the consolidated income statement included in the annual securities report for the fiscal year ending February 2026 exceeds ¥2,500 million.」
The 7th Series of Share Acquisition Rights (paid stock options) was issued to the Representative Director in 460 units, representing 46,000 underlying shares. The exercise condition was consolidated operating income of more than ¥2.5 billion for the fiscal year ending February 2026, and the exercise period was set from 1 June 2026 to 31 May 2031.